TITLE

Reconsidering lactate as a sepsis risk biomarker

AUTHOR(S)
Moran, John L.; Santamaria, John
PUB. DATE
October 2017
SOURCE
PLoS ONE;10/03/2017, Vol. 12 Issue 10, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: There has been renewed interest in lactate as a risk biomarker in sepsis and septic shock. However, the ability of the odds ratio (OR) and change in the area under the receiver operator characteristic curve (AUC-ROC) to assess biomarker added-value has been questioned. Design, setting and participants: A sepsis cohort was identified from the ICU database of an Australian tertiary referral hospital using APACHE III diagnostic codes. Demographic information, APACHE III scores, 24-hour post-admission patient lactate levels, and hospital mortality were accessed. Measurements and main results: Hospital mortality was modelled using a base predictive logistic regression model and sequential addition of admission lactate, lactate clearance ([lactateadmission—lactatefinal]/lactateadmission), and area under the lactate-time curve (LTC). Added-value was assessed using lactate index OR; AUC-ROC difference (base-model versus lactate index addition); net (mortality) reclassification index (NRI; range -2 to +2); and net benefit (NB), the number of true positives per patient adjusted for the number of false positives. The data set comprised 717 patients with mean(SD) age and APACHE III score 61.1(16.5) years and 68.3(28.2) respectively; 59.2% were male. Admission lactate was 2.3(2.5) mmol/l; with lactate of ≥ 4 mmol/L (37% hospital mortality) in 17% and patients with lactate < 4 mmol/L having 18% hospital mortality. The admission base-model had an AUC-ROC = 0.81 with admission lactate OR = 1.127 (95%CI: 1.038, 1.224), AUC-ROC difference of 0.0032 (-0.0037, 0.01615; P = 0.61), and NRI 0.240(0.030, 0.464). The over-time model had an AUC-ROC = 0.86 with (i) clearance OR = 0.771, 95%CI: 0.578, 1.030; P = 0.08; AUC-ROC difference 0.001 (-0.003, 0.014; P = 0.78), and NRI 0.109(-0.193, 0.425) and (ii) LTC OR = 0.997, 95%CI: 0.989, 1.005, P = 0.49; AUC-ROC difference 0.004 (-0.002, 0.004; P = 0.34), and NRI 0.111(-0.222, 0.403). NB was not incremented by any lactate index. Conclusions: Lactate added-value assessment is dependent upon the performance of the underlying predictive model and should incorporate risk reclassification and net benefit measures.
ACCESSION #
125495738

 

Related Articles

  • Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Xue, A.; Scarlett, C. J.; Chung, L.; Butturini, G.; Scarpa, A.; Gandy, R.; Wilson, S. R.; Baxter, R. C.; Smith, R. C. // British Journal of Cancer;7/27/2010, Vol. 103 Issue 3, p391 

    Background and aims:The serum/plasma proteome was explored for biomarkers to improve the diagnostic ability of CA19-9 in pancreatic adenocarcinoma (PC).Methods:A Training Set of serum samples from 20 resectable and 18 stage IV PC patients, 54 disease controls (DCs) and 68 healthy volunteers...

  • Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): A possible new marker of systemic endothelial dysfunction? Rafael Sánchez-Villanueva; Auxiliadora Bajo; Gloria del Peso; M-Jose Fernandez-Reyes; Elena González; Sara Romero; Patricia Estrada; Rafael Selgas // Nephrology Dialysis Transplantation;Mar2009, Vol. 24 Issue 3, p1009 

    Background. Patients starting peritoneal dialysis (PD) with active cardiovascular disease (CVD) show higher protein and albumin levels in peritoneal effluent. Peripheral arterial disease (PAD) is increasingly recognized as an entity particularly associated with higher mortality. Methods. To...

  • Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes. Gruden, Gabriella; Barutta, Federica; Chaturvedi, Nish; Schalkwijk, Casper; Stehouwer, Coen D.; Witte, Daniel R.; Fuller, John H.; Perin, Paolo Cavallo; Bruno, Graziella // Diabetes Care;Jul2012, Vol. 35 Issue 7, p1598 

    OBJECTIVE--Frequent episodes of severe hypoglycemia may increase the risk of cardiovascular disease (CVD) in people with diabetes. Our aim was to study the relationship between severe hypoglycemic episodes and CVD incidence in subjects with type 1 diabetes, and further, to assess if markers of...

  • 1:4 matched case-control study on influential factor of early onset neonatal sepsis. Z. JIANG; G.-Y. YE // European Review for Medical & Pharmacological Sciences;Sep2013, Vol. 17 Issue 18, p2460 

    BACKGROUND: Bacteria, funghi, viruses and protozoa can lead to neonatal sepsis. Neonatal sepsis is the leading cause of infectious disease onset and death in many neonates. AIM: To explore the major risk factors of early-onset neonatal sepsis and provide a scientific basis for strategies of...

  • Can Procalcitonin Distinguish Sepsis from Other Causes of SIRS? Luks, Andrew M. // Critical Care Alert;Jun2007, Vol. 15 Issue 3, p19 

    Several studies have suggested that procalcitonin may be a useful biochemical marker to differentiate sepsis from other, non-infectious, causes of the systemic inflammatory response syndrome (SIRS), such as pancreatitis. Tang and colleagues conducted a meta-analysis of these studies in order to...

  • Factors Associated with Delay in the Diagnosis of Oral Cancer. Pitiphat, W.; Diehl, S. R.; Laskaris, G.; Cartsos, V.; Douglass, C. W.; Zavras, A. I. // Journal of Dental Research;Mar2002, Vol. 81 Issue 3, p192 

    Early detection and treatment improve the prognosis for oral cancer. Delays from the onset of symptoms to clinical diagnosis are common. Our aim is to identify factors associated with this delay. Between 1995 and 1998, we interviewed 105 consecutive patients with histologically confirmed oral...

  • Biomarker may detect GVHD of the gastrointestinal tract after HSCT.  // Hem/Onc Today;11/25/2011, Vol. 12 Issue 22, p31 

    The article presents a study that deals with a plasma biomarker that can help physicians identify patients with cancer who are at the greater risk for graft-versus-host disease after hematopoietic stem cell transplantation.

  • Methods for Data Selection in Medical Databases: The Binary Logistic Regression - Relations with the Calculated Risks. Dascalu, Cristina G.; Carausu, Elena Mihaela; Manuc, Daniela // International Journal of Biomedical Sciences;2008, Vol. 3 Issue 1, p30 

    The medical studies often require different methods for parameters selection, as a second step of processing, after the database's designing and filling with information. One common task is the selection of fields that act as risk factors using wellknown methods, in order to find the most...

  • Methods for Data Selection in Medical Databases: The Binary Logistic Regression - Relations with the Calculated Risks. Dascalu, Cristina G.; Carausu, Elena Mihaela; Manuc, Daniela // Proceedings of World Academy of Science: Engineering & Technolog;Apr2008, Vol. 40, p278 

    The medical studies often require different methods for parameters selection, as a second step of processing, after the database's designing and filling with information. One common task is the selection of fields that act as risk factors using well-known methods, in order to find the most...

  • One Elevated Bladder Pressure Measurement May Not Be Enough to Diagnose Abdominal Compartment Syndrome. YOUNG, ANDREW JOSEPH; WEBER, WILLIAM; WOLFE, LUKE; IVATURY, RAO R.; DUANE, THERESE MARIE // American Surgeon;Feb2013, Vol. 79 Issue 2, p135 

    Bladder pressure measurements (BPMs) are considered a key component in the diagnosis of abdominal compartment syndrome (ACS). The purpose of this observational review was to determine risk factors of ACS and associated mortality with particular focus on the role of BPM. A retrospective trauma...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics